OTCMKTS:INNV InnovAge (INNV) Stock Price, News & Analysis → AI Bubble Now at Critical Mass (From Porter & Company) (Ad) Free INNV Stock Alerts $4.34 +0.10 (+2.36%) (As of 03/27/2024 ET) Add Compare Share Share Today's Range$4.30▼$4.6550-Day Range$4.24▼$5.8952-Week Range$3.96▼$8.15Volume11,944 shsAverage Volume22,559 shsMarket Capitalization$589.80 millionP/E RatioN/ADividend YieldN/APrice Target$7.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsStock AnalysisAnalyst ForecastsChartEarningsFinancialsHeadlinesInsider TradesOwnershipSEC Filings Get InnovAge alerts: Email Address InnovAge MarketRank™ Stock AnalysisAnalyst Rating0.00 Rating ScoreUpside/Downside61.3% Upside$7.00 Price TargetShort InterestN/ADividend StrengthN/ASustainabilityN/ANews SentimentN/AInsider TradingN/AProj. Earnings GrowthGrowingFrom ($0.25) to ($0.05) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.0.12 out of 5 stars 2.0 Analyst's Opinion Price Target Upside/DownsideAccording to analysts' consensus price target of $7.00, InnovAge has a forecasted upside of 61.3% from its current price of $4.34.Amount of Analyst CoverageInnovAge has received no research coverage in the past 90 days. Previous Next N/A Short Interest Short InterestThere is no current short interest data available for INNV. Previous Next 0.0 Dividend Strength Dividend YieldInnovAge does not currently pay a dividend.Dividend GrowthInnovAge does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for INNV. Previous Next 0.6 News and Social Media Coverage News Coverage This WeekMarketBeat has tracked 1 news article for InnovAge this week, compared to 0 articles on an average week.Search Interest3 people have searched for INNV on MarketBeat in the last 30 days. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, InnovAge insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 0.41% of the stock of InnovAge is held by insiders.Percentage Held by InstitutionsOnly 12.17% of the stock of InnovAge is held by institutions. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for InnovAge are expected to grow in the coming year, from ($0.25) to ($0.05) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of InnovAge is -14.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of InnovAge is -14.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioInnovAge has a P/B Ratio of 1.74. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Porter & CompanyAI Bubble Now at Critical MassWashington, D.C., has just issued its first round of new artificial-intelligence (“AI”) regulations. And a flood of additional AI bills is making its way through Congress. Nasdaq reports this could bring a screeching halt to the AI stock boom.Simply click here now to read The Big AI Die-Up. About InnovAge Stock (OTCMKTS:INNV)InnovAge Holding Corp. manages and provides a range of medical and ancillary services for seniors in need of care and support to live independently in their homes and communities. The company manages its business through Program of All-Inclusive Care for the Elderly (PACE) approach. It also offers in-home care services consisting of skilled, unskilled, and personal care; in-center services, such as primary care, physical therapy, occupational therapy, speech therapy, dental services, mental health and psychiatric services, meals, and activities; transportation to the PACE center and third-party medical appointments; and care management. The company serves participants in the United States; and operates PACE centers in Colorado, California, New Mexico, Pennsylvania, and Virginia. The company was formerly known as TCO Group Holdings, Inc. and changed its name to InnovAge Holding Corp. in January 2021. InnovAge Holding Corp. was founded in 2007 and is headquartered in Denver, Colorado.Read More INNV Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart INNV Stock News HeadlinesMarch 27, 2024 | americanbankingnews.comInnovAge (OTCMKTS:INNV) Stock Price Passes Below 50 Day Moving Average of $5.16March 19, 2024 | americanbankingnews.comInnovAge (OTCMKTS:INNV) Stock Price Passes Below 50 Day Moving Average of $5.30March 28, 2024 | Porter & Company (Ad)AI Bubble Now at Critical MassWashington, D.C., has just issued its first round of new artificial-intelligence (“AI”) regulations. And a flood of additional AI bills is making its way through Congress. Nasdaq reports this could bring a screeching halt to the AI stock boom.February 22, 2024 | benzinga.comInnovAge Holding Stock (NASDAQ:INNV) Earnings Dates and Earning CallsFebruary 9, 2024 | finance.yahoo.comAnalysts Have Made A Financial Statement On InnovAge Holding Corp.'s (NASDAQ:INNV) Second-Quarter ReportFebruary 8, 2024 | au.finance.yahoo.comCar-sharing company Getaround cuts one-third of US workforceFebruary 8, 2024 | au.lifestyle.yahoo.comSingapore Takes Large Stake in Kohl’sFebruary 8, 2024 | au.finance.yahoo.com8 Purchases Boomers Should Never Make During RetirementMarch 28, 2024 | Porter & Company (Ad)AI Bubble Now at Critical MassWashington, D.C., has just issued its first round of new artificial-intelligence (“AI”) regulations. And a flood of additional AI bills is making its way through Congress. Nasdaq reports this could bring a screeching halt to the AI stock boom.February 8, 2024 | au.finance.yahoo.comUnilever takes sales hit in Indonesia over anti-Israel boycottsFebruary 8, 2024 | finance.yahoo.comInnovAge Holding Second Quarter 2024 Earnings: Beats ExpectationsFebruary 8, 2024 | finance.yahoo.comInnovAge to Host Investor Day on February 27, 2024February 5, 2024 | benzinga.comEarnings Outlook For InnovAge HoldingJanuary 23, 2024 | finance.yahoo.comInnovAge to Announce Fiscal Second Quarter 2024 Financial Results and Host Conference Call Tuesday, February 6, 2024December 1, 2023 | finance.yahoo.comInnovAge Announces Acquisition of ConcertoCare’s PACE ProgramsNovember 7, 2023 | finance.yahoo.comInnovAge Announces Financial Results For The Fiscal First Quarter Ended September 30, 2023September 13, 2023 | finance.yahoo.comInnovAge Holding Corp. (NASDAQ:INNV) Q4 2023 Earnings Call TranscriptSeptember 11, 2023 | benzinga.comEarnings Preview: InnovAge HoldingSeptember 10, 2023 | msn.comDow futures trade flat, fresh inflation data in focusSeptember 10, 2023 | msn.comINNVInnovAge Holding Corp.August 29, 2023 | finance.yahoo.comInnovAge to Announce Fiscal Fourth Quarter 2023 Financial Results and Host Conference Call Tuesday, September 12, 2023August 16, 2023 | benzinga.comPerformance Food Group, Stride, Progressive, H&R Block And Other Big Stocks Moving Higher On WednesdayAugust 14, 2023 | finance.yahoo.comInnovAge Strengthens Board with Appointment of New Independent DirectorJuly 6, 2023 | bizjournals.comInnovAge taps former health care investment banker for newly vacated CFO roleJuly 5, 2023 | finance.yahoo.comInnovAge Names Ben Adams as New Chief Financial OfficerJuly 5, 2023 | finance.yahoo.comEstimating The Intrinsic Value Of InnovAge Holding Corp. (NASDAQ:INNV)June 27, 2023 | msn.comInnovAge Holding: EBITDA In Focus With No More SanctionsSee More Headlines Receive INNV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for InnovAge and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/06/2024Today3/28/2024Fiscal Year End6/30/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Medical Care Facilities Sub-IndustryN/A Current SymbolOTCMKTS:INNV Previous SymbolNASDAQ:INNV CUSIPN/A CIK1411879 Webwww.innovuspharma.com Phone844-803-8745FaxN/AEmployees2,100Year FoundedN/APrice Target and Rating Average Stock Price Target$7.00 High Stock Price Target$7.00 Low Stock Price Target$7.00 Potential Upside/Downside+61.3%Consensus Rating Rating Score (0-4)0.00 Research Coverage0 Analysts Profitability EPS (Most Recent Fiscal Year)($0.25) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-6,520,000.00 Net Margins-6.17% Pretax Margin-7.63% Return on Equity-13.04% Return on Assets-7.48% Debt Debt-to-Equity Ratio0.25 Current Ratio1.57 Quick Ratio1.57 Sales & Book Value Annual Sales$720.80 million Price / Sales0.82 Cash Flow$0.07 per share Price / Cash Flow65.41 Book Value$2.50 per share Price / Book1.74Miscellaneous Outstanding Shares135,899,000Free Float135,311,000Market Cap$589.80 million OptionableNot Optionable Beta0.16 10 Best Stocks to Own in 2024Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio. Get This Free Report Key ExecutivesMr. Patrick Blair (Age 53)President & CEO Comp: $1.51MMs. Nicole D'Amato (Age 45)Chief Legal Officer & Corporate Secretary Comp: $678.76kDr. Richard A. Feifer FACP (Age 57)M.D., M.P.H., Chief Medical Officer Comp: $588.97kMr. Edward Moore Kennedy Jr. (Age 63)J.D., Independent Director Comp: $100kHon. Marilyn Barbour Tavenner M.H.A. (Age 62)R.N., Independent Director Comp: $120kMr. Benjamin Crowninshield Adams (Age 60)Chief Financial Officer Ms. Christine Bent (Age 53)Chief Operations Officer Ms. Cara BabachicosChief Information OfficerMr. Ryan KubotaDirector of Investor RelationsMs. Olivia PattonChief Compliance OfficerMore ExecutivesKey CompetitorsRyman HealthcareOTCMKTS:RYHTYTravere TherapeuticsNASDAQ:TVTXCOMPASS PathwaysNASDAQ:CMPSGH ResearchNASDAQ:GHRSAnaptysBioNASDAQ:ANABView All CompetitorsInsidersNicole DamatoSold 1,866 sharesTotal: $13,192.62 ($7.07/share)Nicole DamatoSold 411 sharesTotal: $2,909.88 ($7.08/share)Nicole DamatoSold 6,422 sharesTotal: $45,596.20 ($7.10/share)Nicole DamatoSold 4,173 sharesTotal: $30,379.44 ($7.28/share)Nicole DamatoSold 2,101 sharesTotal: $15,253.26 ($7.26/share)View All Insider Transactions INNV Stock Analysis - Frequently Asked Questions What is InnovAge's stock price target for 2024? 0 brokerages have issued twelve-month target prices for InnovAge's shares. Their INNV share price targets range from $7.00 to $7.00. On average, they predict the company's stock price to reach $7.00 in the next twelve months. This suggests a possible upside of 61.3% from the stock's current price. View analysts price targets for INNV or view top-rated stocks among Wall Street analysts. How have INNV shares performed in 2024? InnovAge's stock was trading at $6.00 at the beginning of the year. Since then, INNV stock has decreased by 27.7% and is now trading at $4.34. View the best growth stocks for 2024 here. How were InnovAge's earnings last quarter? InnovAge Holding Corp. (OTCMKTS:INNV) released its earnings results on Tuesday, February, 6th. The company reported ($0.03) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.03). The business earned $188.90 million during the quarter, compared to the consensus estimate of $181.51 million. InnovAge had a negative net margin of 6.17% and a negative trailing twelve-month return on equity of 13.04%. What other stocks do shareholders of InnovAge own? Based on aggregate information from My MarketBeat watchlists, some companies that other InnovAge investors own include EEStor Co. (ESU.V) (ESU), Antares Pharma (ATRS), Federal National Mortgage Association (FNMA), Medicines (MDCO), Frontier Communications (FTR), FedEx (FDX), Republic First Bancorp (FRBK), Aytu BioPharma (AYTU), NVIDIA (NVDA) and Pacific Premier Bancorp (PPBI). How do I buy shares of InnovAge? Shares of INNV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:INNV) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeGrab Your Free Bitcoin Today!Crypto Swap ProfitsTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingFed launches fourth dollar overhaulStansberry ResearchForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding InnovAge Holding Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.